Cardio Diagnostics (CDIO) Expected to Announce Earnings on Monday

Cardio Diagnostics (NASDAQ:CDIO) will likely be announcing its earnings results before the market opens on Monday, April 7th. Analysts expect the company to announce earnings of ($0.16) per share and revenue of $0.03 million for the quarter.

Cardio Diagnostics Trading Down 7.3 %

NASDAQ CDIO opened at $0.31 on Friday. The firm’s 50 day moving average price is $0.46 and its 200-day moving average price is $0.48. Cardio Diagnostics has a 52-week low of $0.19 and a 52-week high of $1.77.

Cardio Diagnostics Company Profile

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.